Sylvain Beaulieu

1.2k total citations
19 papers, 718 citations indexed

About

Sylvain Beaulieu is a scholar working on Radiology, Nuclear Medicine and Imaging, Pharmacology and Infectious Diseases. According to data from OpenAlex, Sylvain Beaulieu has authored 19 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Pharmacology and 5 papers in Infectious Diseases. Recurrent topics in Sylvain Beaulieu's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Medical Imaging Techniques and Applications (4 papers). Sylvain Beaulieu is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Medical Imaging Techniques and Applications (4 papers). Sylvain Beaulieu collaborates with scholars based in Canada, United States and Egypt. Sylvain Beaulieu's co-authors include Francis F. Arhin, Thomas Parr, Greg Moeck, Ingrid Sarmiento, Geoffrey A. McKay, Adam Belley, Brian G. Rubin, Ernest U. Conrad, Éric Turcotte and Janet F. Eary and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Desalination and American Journal of Roentgenology.

In The Last Decade

Sylvain Beaulieu

19 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvain Beaulieu Canada 11 210 165 116 115 110 19 718
Julie Smet Belgium 13 43 0.2× 78 0.5× 35 0.3× 75 0.7× 67 0.6× 29 673
Natalia Maximova Italy 17 66 0.3× 148 0.9× 20 0.2× 47 0.4× 88 0.8× 79 767
Mohammed Al‐Saeedi Germany 12 28 0.1× 110 0.7× 31 0.3× 147 1.3× 91 0.8× 54 700
J W Smith United States 8 74 0.4× 55 0.3× 12 0.1× 35 0.3× 114 1.0× 17 579
S. Bahadur India 14 29 0.1× 110 0.7× 17 0.1× 154 1.3× 107 1.0× 90 840
Austin Huy Nguyen United States 16 18 0.1× 49 0.3× 59 0.5× 89 0.8× 68 0.6× 38 615
Judith Krey Ludviksen Norway 16 22 0.1× 57 0.3× 27 0.2× 64 0.6× 190 1.7× 41 718
Sharon Henry United States 13 173 0.8× 20 0.1× 15 0.1× 22 0.2× 111 1.0× 22 663

Countries citing papers authored by Sylvain Beaulieu

Since Specialization
Citations

This map shows the geographic impact of Sylvain Beaulieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Beaulieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Beaulieu more than expected).

Fields of papers citing papers by Sylvain Beaulieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Beaulieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Beaulieu. The network helps show where Sylvain Beaulieu may publish in the future.

Co-authorship network of co-authors of Sylvain Beaulieu

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Beaulieu. A scholar is included among the top collaborators of Sylvain Beaulieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Beaulieu. Sylvain Beaulieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sylvestre, Jean‐Philippe, Jean‐Paul Soucy, Sylvain Beaulieu, et al.. (2019). Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images. Alzheimer s & Dementia Translational Research & Clinical Interventions. 5(1). 610–617. 41 indexed citations
2.
Soucy, Jean‐Paul, Jean‐Philippe Sylvestre, Jean Daniel Arbour, et al.. (2018). IC‐P‐190: AN AMYLOID LIGAND‐FREE OPTICAL RETINAL IMAGING METHOD TO PREDICT CEREBRAL AMYLOID PET STATUS. Alzheimer s & Dementia. 14(7S_Part_2). 2 indexed citations
3.
Delouya, Guila, Levon Igidbashian, Manon Bélair, et al.. (2011). 18F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer. Radiotherapy and Oncology. 101(3). 362–368. 54 indexed citations
4.
Lapointe, Jérôme, et al.. (2011). An ocular prosthesis which reacts to light. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7885. 788512–788512. 1 indexed citations
5.
Belley, Adam, Geoffrey A. McKay, Francis F. Arhin, et al.. (2010). Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing. Antimicrobial Agents and Chemotherapy. 54(12). 5369–5371. 96 indexed citations
6.
Beaulieu, Sylvain, et al.. (2010). Reply: The Twilight Saga of Insulin Administration in Hyperglycemic Patients Undergoing 18F-FDG PET. Journal of Nuclear Medicine. 51(3). 498.1–498. 1 indexed citations
7.
Arhin, Francis F., Adam Belley, Geoffrey A. McKay, et al.. (2010). Assessment of Oritavancin Serum Protein Binding across Species. Antimicrobial Agents and Chemotherapy. 54(8). 3481–3483. 16 indexed citations
8.
McKay, Geoffrey A., Sylvain Beaulieu, Francis F. Arhin, et al.. (2009). Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium. Journal of Antimicrobial Chemotherapy. 63(6). 1191–1199. 114 indexed citations
9.
Arhin, Francis F., Geoffrey A. McKay, Sylvain Beaulieu, et al.. (2009). Time–kill kinetics of oritavancin and comparator agents against Streptococcus pyogenes. International Journal of Antimicrobial Agents. 34(6). 550–554. 16 indexed citations
10.
Beaulieu, Sylvain, et al.. (2009). Impact of Intravenous Insulin on 18F-FDG PET in Diabetic Cancer Patients. Journal of Nuclear Medicine. 50(2). 178–183. 47 indexed citations
11.
Arhin, Francis F., Geoffrey A. McKay, Sylvain Beaulieu, et al.. (2009). Impact of human serum albumin on oritavancin in vitro activity against Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease. 65(2). 207–210. 4 indexed citations
12.
McKay, Geoffrey A., Sylvain Beaulieu, Ingrid Sarmiento, et al.. (2009). Impact of Human Serum Albumin on Oritavancin In Vitro Activity against Enterococci. Antimicrobial Agents and Chemotherapy. 53(6). 2687–2689. 15 indexed citations
13.
Beaulieu, Sylvain, et al.. (2007). Chilaiditi Sign on FDG-PET. Clinical Nuclear Medicine. 32(10). 802–804. 4 indexed citations
14.
Rabiller‐Baudry, Murielle, et al.. (2005). Limiting flux in skimmed milk ultrafiltration: impact of electrostatic repulsion due to casein micelles. Desalination. 175(1). 49–59. 39 indexed citations
15.
Beaulieu, Sylvain, et al.. (2005). False-positive "necklace sign" on whole-body thyroid cancer survey--a case report.. PubMed. 33(1). 42–3. 4 indexed citations
16.
Beaulieu, Sylvain, et al.. (2004). Positron Emission Tomography of Schwannomas: Emphasizing Its Potential in Preoperative Planning. American Journal of Roentgenology. 182(4). 971–974. 150 indexed citations
17.
Beaulieu, Sylvain, Paul E. Kinahan, Jeffrey R. Tseng, et al.. (2003). SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.. PubMed. 44(7). 1044–50. 105 indexed citations
18.
19.
Beaulieu, Sylvain, et al.. (1999). Incidental Finding of Hiatal Hernia Uptake on Tc-99m Sestamibi Breast Imaging. Clinical Nuclear Medicine. 24(6). 455–456. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Smet Breakdown of academic impact, for papers by Natalia Maximova Breakdown of academic impact, for papers by Mohammed Al‐Saeedi Breakdown of academic impact, for papers by J W Smith Breakdown of academic impact, for papers by S. Bahadur Breakdown of academic impact, for papers by Austin Huy Nguyen Breakdown of academic impact, for papers by Judith Krey Ludviksen Breakdown of academic impact, for papers by Sharon Henry
Rankless by CCL
2026